Eribaxaban
Eribaxaban (PD348292) is an oral, small-molecule factor Xa inhibitor used in research for preventing and treating venous thromboembolism. It serves as a key pharmacological tool in hematology and thrombosis research, enabling both in vitro enzymatic assays and in vivo preclinical models of thrombosis.
Product Specifications
CAS Number
536748-46-6
Product Name Alternative
PD 348292, PD0348292, PD-0348292, PD 0348292, PD348292, PD-348292, FactorXa, Factor Xa, Eribaxaban
Field of Research
Metabolism Research
Purity
98.99% (May vary between batches)
Solubility
DMSO:100 mg/mL (206.22 mM) ;10% DMSO+40% PEG300+5% Tween-80+45% Saline:2 mg/mL (4.12 mM)
Smiles
C (NC1=C (F) C=C (C=C1) N2C (=O) C=CC=C2) (=O) [C@@H]3N (C (NC4=CC=C (Cl) C=C4) =O) C[C@H] (OC) C3
Molecular Formula
C24H22ClFN4O4
Molecular Weight
484.91
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
